Cargando…
AGuIX(®) from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
AGuIX(®) are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No e...
Ejemplares similares
-
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles
por: Bort, Guillaume, et al.
Publicado: (2020) -
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas, Eloïse, et al.
Publicado: (2017) -
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX(®)-Design Nanoparticles
por: Lerouge, Lucie, et al.
Publicado: (2023) -
Terbium-Based AGuIX-Design Nanoparticle to Mediate X-ray-Induced Photodynamic Therapy
por: Daouk, Joël, et al.
Publicado: (2021) -
AGuIX nanoparticles as a promising platform for image-guided radiation therapy
por: Detappe, Alexandre, et al.
Publicado: (2015)